Trial alert: Safety and efficacy study of Enzalutamide in patients with nonmetastatic castration-resistant prostate cancer

The trial started in December 2013 in Calgary, Toronto, Quebec, Montreal and Greenfield Park, the information was updated in June 2014:

Official Title

A Multinational, Phase 3, Randomized, Double Blind, Placebo Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration Resistant Prostate Cancer
Summary:

The purpose of this study is to assess the safety and efficacy of enzalutamide in patients with non metastatic prostate cancer.
Trial Description

Primary Outcome:

Metastasis Free Survival (MFS)

See more details here.